FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1498131831> ?p ?o ?g. }

• W1498131831 endingPage "3161" @default.
• W1498131831 startingPage "3154" @default.
• W1498131831 abstract "A cassette-microdose (MD) clinical study was performed to demonstrate its usefulness for identifying the most promising compound for oral use. Three Ca-channel blockers (nifedipine, nicardipine, and diltiazem) were chosen as model drugs. In the MD clinical study, a cassette-dose method was employed in which three model drugs were administered simultaneously. Both intravenous (i.v.) and oral (p.o.) administration studies were conducted to calculate the oral bioavailability (BA). For comparison, p.o. studies with therapeutic dose (ThD) levels were also performed. In all studies, blood concentrations of each drug were successfully determined using liquid chromatography-mass spectrometry with the lower limit of quantification of 0.2-2.0 pg/mL. Oral BA of nifedipine in the MD study was approximately 50% and in the same range with that obtained in the ThD study, whereas other two drugs showed significantly lower BA in the MD study, indicating a dose-dependent absorption. In addition, compared with the ThD study, absorption of nicardipine was delayed in the MD study. As a result, nifedipine was considered to be most promising for oral use. In conclusion, a cassette-MD clinical study is of advantage for oral drug development that enables to identify the candidate having desired properties for oral use." @default.
• W1498131831 created "2016-06-24" @default.
• W1498131831 creator A5001543955 @default.
• W1498131831 creator A5015324642 @default.
• W1498131831 creator A5015667650 @default.
• W1498131831 creator A5027984186 @default.
• W1498131831 creator A5029718117 @default.
• W1498131831 creator A5038921858 @default.
• W1498131831 creator A5057315592 @default.
• W1498131831 creator A5081112248 @default.
• W1498131831 creator A5090758136 @default.
• W1498131831 creator A5047298624 @default.
• W1498131831 date "2015-09-01" @default.
• W1498131831 modified "2023-09-26" @default.
• W1498131831 title "An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug Development" @default.
• W1498131831 cites W1838282487 @default.
• W1498131831 cites W1884477691 @default.
• W1498131831 cites W1895993106 @default.
• W1498131831 cites W1973810935 @default.
• W1498131831 cites W1987469331 @default.
• W1498131831 cites W1997253579 @default.
• W1498131831 cites W1997362383 @default.
• W1498131831 cites W2004223135 @default.
• W1498131831 cites W2012712901 @default.
• W1498131831 cites W2015210217 @default.
• W1498131831 cites W2018429921 @default.
• W1498131831 cites W2034045987 @default.
• W1498131831 cites W2035635857 @default.
• W1498131831 cites W2037182554 @default.
• W1498131831 cites W2045189858 @default.
• W1498131831 cites W2048992861 @default.
• W1498131831 cites W2083003895 @default.
• W1498131831 cites W2089788148 @default.
• W1498131831 cites W2092642790 @default.
• W1498131831 cites W2098028363 @default.
• W1498131831 cites W2099918113 @default.
• W1498131831 cites W2100104377 @default.
• W1498131831 cites W2103126842 @default.
• W1498131831 cites W2129463334 @default.
• W1498131831 cites W2136439569 @default.
• W1498131831 cites W2138212930 @default.
• W1498131831 cites W2416348239 @default.
• W1498131831 cites W2416437239 @default.
• W1498131831 cites W32337113 @default.
• W1498131831 doi "https://doi.org/10.1002/jps.24499" @default.
• W1498131831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26037531" @default.
• W1498131831 hasPublicationYear "2015" @default.
• W1498131831 type Work @default.
• W1498131831 sameAs 1498131831 @default.
• W1498131831 citedByCount "9" @default.
• W1498131831 countsByYear W14981318312016 @default.
• W1498131831 countsByYear W14981318312017 @default.
• W1498131831 countsByYear W14981318312019 @default.
• W1498131831 countsByYear W14981318312020 @default.
• W1498131831 crossrefType "journal-article" @default.
• W1498131831 hasAuthorship W1498131831A5001543955 @default.
• W1498131831 hasAuthorship W1498131831A5015324642 @default.
• W1498131831 hasAuthorship W1498131831A5015667650 @default.
• W1498131831 hasAuthorship W1498131831A5027984186 @default.
• W1498131831 hasAuthorship W1498131831A5029718117 @default.
• W1498131831 hasAuthorship W1498131831A5038921858 @default.
• W1498131831 hasAuthorship W1498131831A5047298624 @default.
• W1498131831 hasAuthorship W1498131831A5057315592 @default.
• W1498131831 hasAuthorship W1498131831A5081112248 @default.
• W1498131831 hasAuthorship W1498131831A5090758136 @default.
• W1498131831 hasBestOaLocation W14981318311 @default.
• W1498131831 hasConcept C112705442 @default.
• W1498131831 hasConcept C121332964 @default.
• W1498131831 hasConcept C125287762 @default.
• W1498131831 hasConcept C126322002 @default.
• W1498131831 hasConcept C181389837 @default.
• W1498131831 hasConcept C24890656 @default.
• W1498131831 hasConcept C2776741139 @default.
• W1498131831 hasConcept C2777056448 @default.
• W1498131831 hasConcept C2778043224 @default.
• W1498131831 hasConcept C2779066535 @default.
• W1498131831 hasConcept C2780035454 @default.
• W1498131831 hasConcept C2780913584 @default.
• W1498131831 hasConcept C519063684 @default.
• W1498131831 hasConcept C71924100 @default.
• W1498131831 hasConcept C98274493 @default.
• W1498131831 hasConceptScore W1498131831C112705442 @default.
• W1498131831 hasConceptScore W1498131831C121332964 @default.
• W1498131831 hasConceptScore W1498131831C125287762 @default.
• W1498131831 hasConceptScore W1498131831C126322002 @default.
• W1498131831 hasConceptScore W1498131831C181389837 @default.
• W1498131831 hasConceptScore W1498131831C24890656 @default.
• W1498131831 hasConceptScore W1498131831C2776741139 @default.
• W1498131831 hasConceptScore W1498131831C2777056448 @default.
• W1498131831 hasConceptScore W1498131831C2778043224 @default.
• W1498131831 hasConceptScore W1498131831C2779066535 @default.
• W1498131831 hasConceptScore W1498131831C2780035454 @default.
• W1498131831 hasConceptScore W1498131831C2780913584 @default.
• W1498131831 hasConceptScore W1498131831C519063684 @default.
• W1498131831 hasConceptScore W1498131831C71924100 @default.
• W1498131831 hasConceptScore W1498131831C98274493 @default.
• W1498131831 hasIssue "9" @default.
• W1498131831 hasLocation W14981318311 @default.

• next